CIBC WORLD MARKET INC. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
CIBC WORLD MARKET INC. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$487
-17.7%
15,399
+6.0%
0.00%0.0%
Q2 2023$592
+105.6%
14,523
+87.8%
0.00%
+100.0%
Q1 2023$288
-2.7%
7,732
-9.0%
0.00%0.0%
Q4 2022$296
-99.9%
8,497
+5.6%
0.00%
-50.0%
Q3 2022$450,000
-3.8%
8,044
-11.0%
0.00%0.0%
Q2 2022$468,000
+36.0%
9,034
+90.6%
0.00%
+100.0%
Q1 2022$344,000
-9.5%
4,740
+47.3%
0.00%0.0%
Q4 2021$380,000
+14.8%
3,218
+30.5%
0.00%0.0%
Q3 2021$331,000
-35.4%
2,466
-22.0%
0.00%0.0%
Q2 2021$512,000
+21.3%
3,162
-39.9%
0.00%0.0%
Q1 2021$422,0005,2600.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders